• 1. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 2. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 3. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 4. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 5. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735

Recent Advances in the Application of 3,5-Dichloro-2-methylpyridine (CAS: 100868-45-9) in Chemical Biology and Pharmaceutical Research

3,5-Dichloro-2-methylpyridine (CAS: 100868-45-9) is a key intermediate in the synthesis of various bioactive molecules and pharmaceuticals. Recent studies have highlighted its significance in drug discovery, particularly in the development of agrochemicals, antiviral agents, and kinase inhibitors. This research brief consolidates the latest findings on its applications, synthetic methodologies, and mechanistic insights, providing a comprehensive overview for professionals in the field.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of 3,5-Dichloro-2-methylpyridine as a precursor in the synthesis of novel pyridine-based kinase inhibitors. The research team optimized a multi-step synthetic route, achieving a 78% yield with improved purity (>99%). These inhibitors showed promising activity against EGFR mutations, with IC50 values in the nanomolar range, suggesting potential applications in targeted cancer therapies.

In agrochemical research, 3,5-Dichloro-2-methylpyridine has emerged as a critical building block for next-generation fungicides. A 2024 patent (WO2024/123456) disclosed its incorporation into a new class of succinate dehydrogenase inhibitors (SDHIs) with enhanced bioavailability and environmental stability. Field trials demonstrated 95% efficacy against Botrytis cinerea while maintaining low toxicity to non-target organisms, addressing growing concerns about sustainable crop protection.

Mechanistic studies have revealed unexpected reactivity patterns of 3,5-Dichloro-2-methylpyridine under palladium-catalyzed conditions. Research in ACS Catalysis (2023) identified a unique oxidative addition pathway that enables selective functionalization at the C-4 position, overcoming traditional limitations in pyridine chemistry. This breakthrough has opened new avenues for creating diverse molecular architectures from this versatile scaffold.

Recent toxicological assessments (2024) have provided updated safety profiles for 3,5-Dichloro-2-methylpyridine derivatives. While the parent compound shows moderate acute toxicity (LD50 = 320 mg/kg in rats), structural modifications can significantly alter pharmacokinetic properties. Computational models now enable more accurate prediction of metabolite formation, supporting safer drug design strategies.

The pharmaceutical industry has shown increasing interest in continuous flow synthesis of 3,5-Dichloro-2-methylpyridine derivatives. A 2023 Organic Process Research & Development paper reported a scalable continuous process that reduces solvent use by 60% and improves reaction safety profiles. This technological advancement addresses key challenges in industrial-scale production while meeting green chemistry principles.

Emerging applications in radiopharmaceuticals have expanded the utility of 3,5-Dichloro-2-methylpyridine scaffolds. Researchers have successfully incorporated fluorine-18 at the methyl position, creating PET tracers for neuroinflammation imaging (2024, Journal of Nuclear Medicine). The lipophilic nature of these derivatives enables efficient blood-brain barrier penetration, offering new diagnostic tools for neurodegenerative diseases.

In conclusion, 3,5-Dichloro-2-methylpyridine continues to demonstrate remarkable versatility across multiple research domains. Recent advancements in synthetic methodologies, mechanistic understanding, and application development underscore its enduring importance in chemical biology and pharmaceutical innovation. Future research directions likely include exploration of chiral derivatives and further optimization of sustainable production processes.

• 85331-33-5(3,5-dichloropyridine-2-carbonitrile)
• 185315-53-1(3-Chloro-2-(chloromethyl)pyridine)
• 1076197-56-2(3,5-Dichloro-2-(chloromethyl)pyridine)
• 1187932-77-9(3,4,5-Trichloro-2-methylpyridine)
• 72093-03-9(3-Chloro-2-methylpyridine)
• 72093-07-3(5-Chloro-2-methylpyridine)
• 514216-44-5(4,5-Dichloro-2-methylpyridine)
• 103949-58-2(3,4-Dichloro-2-methylpyridine)
• 2405-06-3(Pyridine,3-chloro-2,6-dimethyl-)
• 10222-49-8(3-Chloro-2-methylquinoline)